![]() ![]() People who get the jab are more likely to get side effects after the first dose than the second, he added.Īsked whether people might experience some side effects, he told BBC Breakfast: "Yes, there are. Professor Anthony Harnden, deputy chairman of the Joint Committee on Vaccination and Immunisation, said women were more likely to get side effects from the Oxford jab. Our Science Editor Sarah Knapton has the full details here That means that the risk of suffering from DVT or a PE after vaccination is 37 in 17 million, or roughly one in 460,000. The company estimates that 17 million AstraZeneca vaccines have been delivered in that time. ![]() So should people be worried if they have been immunised with the British vaccine? The numbers suggest not.Īccording to the charity Thrombosis UK, up to one in 1,000 people each year will experience a dangerous blood clot in a vein, known as a venous thrombosis. That means about 66,000 people in Britain might be expected to suffer a blood clot annually – or 1,222 a week.Īccording to AstraZeneca, there have been 15 events of deep vein thrombosis (DVT) and 22 events of pulmonary embolism (PE) reported among those given the vaccine so far across the EU and UK, based cases up to March 8. In the latest twist, Ireland, the Netherlands, Germany, Denmark, Iceland, Bulgaria, France, Italy and Norway have all halted their AstraZeneca rollouts over fears that the jab is causing blood clots. Then several European countries ruled it was unsuitable for over-65s. The Oxford/AstraZeneca vaccine has not had an easy few months.įirst, trial results suggested it was not as effective as other jabs. Health Minister Carolina Darias send a “message of calm to citizens”, noting that almost 940,000 AstraZeneca shots had been administered in Spain with only one possible case of a related blood clot. “We are talking about very few cases, 11 so far, and 17 million AstraZeneca vaccines have been administered in the world,” Dr Lamas said, adding that Spain had asked the UK health authorities about their experience and been told that Britain had also registered one thrombosis case in a vaccinated person. María Jesús Lamas, the director of the Spanish Medicines Agency, said that the number of cases of thrombosis that could be linked to the vaccine was still very small, but Spain will wait for the result of an investigation by the EMA’s Pharmacovigilance Risk Assessment Committee before deciding whether to resume use of AstraZeneca and, if so, in which groups of the population. Spain became the latest European country to suspend the use of the AstraZeneca Covid vaccine after one case of thrombosis in a person who had been vaccinated required treatment over the weekend. Portugal will be removed from England's travel ban red list, the Department for Transport has announced. The WHO's chief scientist said there had been no deaths documented linked to the Covid-19 vaccines, amid 300 million people who have had at least one dose.There is a risk of a further coronavirus surge after this summer, Wales's deputy chief medical officer has warned. Professor Sir David Spiegelhalter, a statistician from the University of Cambridge, said the decision to pause the AstraZeneca vaccine rollout in some countries could be doing "more harm than good". Boris Johnson has said the UK's medicines regulator sees "no reason to discontinue" using the Oxford/AstraZeneca vaccine despite several countries suspending its use.AstraZeneca said it had conducted a review covering more than 17 million people vaccinated in the European Union and the UK which had shown no evidence of an increased risk of blood clots.Spain has joined France, Germany and Italy in suspending its use of the AstraZeneca's Covid-19 vaccine over reports of dangerous blood clots in connection with the shot.Here is your evening roundup of today's news: ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |